mRNA |
CUDC-101 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0001 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0001 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
VX-680 |
GDSC1000 |
pan-cancer |
AAC |
-0.19 |
0.0002 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
LAQ824 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0004 |
mRNA |
OSU-03012 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0004 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |